Key Metrics
3.1
CiteScore
CiteScore
CiteScore measures average citations received per document published in the serial.
< 5
Impact Factor
Impact Factor
Impact factor of a journal is calculated by dividing the number of current year citations to the source items published in that journal during the previous two years.
Q3
Urology
SJR
- Q2 Urology
- Q3 Oncology
SJR
SJR
SCImago Journal Rank measures weighted citations received by the serial. Citation weighting depends on subject field and prestige (SJR) of the citing serial.
0.63
SNIP
SNIP
Source Normalized Impact per Paper measures actual citations received relative to citations expected for the serial’s subject field.
Topics Covered
- Bladder cancer
- Complete response
- Systematic review
- Overall survival
- Urinary biomarkers
- Urothelial carcinoma
- Bladder tumor
- Progression-free survival
- Chemoradiotherapy
- Advanced bladder cancer
- Quality of life
- Bcg therapy
- Severe acute respiratory syndrome coronavirus
- Prostate carcinoma
- Cystoscopy
- Carcinoma in situ
- Urinary diversion
Journal Specifications
| Overview | |
| Publisher | IOS PRESS |
| Language | English |
| Frequency | Quarterly |
| General Details | |
| Language | English |
| Frequency | Quarterly |
| Publication Start Year | 2015 |
| Publisher URL | Visit website |
| Website URL | Visit website |
Planning to publish in Bladder Cancer ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations
Looking for the right journals to submit your mansucript?
Upload your manuscript and get a submission readiness score and other journal recommendations.
Check my PaperRecently Published Papers
-
Full paper
Single-cell RNA sequencing and spatial transcriptome analysis in bladder cancer: Current status and future perspectives.
- 1 Feb 25
- Bladder cancer (Amsterdam, Netherlands)
-
Full paper
Impact of DNA repair deficiency on sensitivity to antibody-drug conjugate (ADC) payloads in bladder cancer.
- 1 Feb 25
- Bladder cancer (Amsterdam, Netherlands)
-
Full paper
Practice patterns and outcomes of conventional versus split-dose cisplatin in neoadjuvant ddMVAC in bladder cancer.
- 1 Jan 25
- Bladder cancer (Amsterdam, Netherlands)
-
Full paper
Management of bladder cancer in kidney transplant recipients: A narrative review.
- 1 Jan 25
- Bladder cancer (Amsterdam, Netherlands)
-
Full paper
Summary from the NCI clinical trials planning meeting on next generation of clinical trials in non-muscle invasive bladder cancer.
- 1 Jan 25
- Bladder cancer (Amsterdam, Netherlands)
-
Full paper
BCG therapy for bladder cancer: Exploring patient experiences and concerns through artificial intelligence-based social media analysis.
- 1 Dec 24
- Bladder cancer (Amsterdam, Netherlands)
Scite analysis
Powered by scite_
432 articles received 2.9k citations see all
- 104 Supporting
- 2,706 Mentioning
- 25 Contrasting
Editorial notices
- 0 Retractions
- 0 Withdrawals
- 0 Corrections
- 2 Errata
- 0 Expression of Concern
FAQs
How long has Bladder Cancer been actively publishing?
Bladder Cancer has been in operation since 2015 till date.
What is the publishing frequency of Bladder Cancer ?
Bladder Cancer published with a Quarterly frequency.
How many articles did Bladder Cancer publish last years ?
In 2024, Bladder Cancer published 32 articles.
What is the eISSN & pISSN for Bladder Cancer ?
For Bladder Cancer,eISSN is 2352-3735 and pISSN is2352-3727.
What is Citescore for Bladder Cancer ?
Citescore for Bladder Cancer is 3.1.
What is SNIP score for Bladder Cancer ?
SNIP score for Bladder Cancer is 0.63.
What is the SJR for Bladder Cancer ?
SJR for Bladder Cancer is Q3.
Who is the publisher of Bladder Cancer ?
IOS PRESS is the publisher of Bladder Cancer.